|Bid||158.38 x 800|
|Ask||158.50 x 800|
|Day's Range||155.47 - 158.46|
|52 Week Range||144.95 - 181.04|
|Beta (5Y Monthly)||0.58|
|PE Ratio (TTM)||29.66|
|Forward Dividend & Yield||4.76 (3.01%)|
|Ex-Dividend Date||Nov 20, 2023|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for JNJ
California State Teachers' Retirement System, or Calsters, cut positions in AMC Entertainment, NIO, Spotify, and Johnson & Johnson in the third quarter.
It's surely a bad sign for the US economy, right? Not so fast.
Warren Buffett is known for owning shares in some of America's leading companies, in industries from financials to oil. One particular area he hasn't invested too heavily in, though, is healthcare -- the risks of drug development, high costs of research, and complexity of the science behind many pharma pipelines are all elements that don't go hand-in-hand with the billionaire's investment strategy. Considering Buffett's top stock picking skills and long-term performance, you may be temped to sell or avoid J&J too.